HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?

Discrepancies have been reported between HER2 status in primary breast cancer and micrometastatic cells in bone marrow. The aim of this study was to assess HER2 gene status in micrometastatic cells in bone marrow and corresponding primary tumour. Micrometastatic cells were detected in bone marrow as...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent-Salomon, A, Pierga, J-Y, Couturier, J, d'Enghien, C D, Nos, C, Sigal-Zafrani, B, Lae, M, Fréneaux, P, Diéras, V, Thiéry, J-P, Sastre-Garau, X
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360046/
https://www.ncbi.nlm.nih.gov/pubmed/17262082
http://dx.doi.org/10.1038/sj.bjc.6603584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360046/
https://www.ncbi.nlm.nih.gov/pubmed/17262082
http://dx.doi.org/10.1038/sj.bjc.6603584

Ejemplares similares